The company said it will appoint a new Chairman at the next Board meeting.
Investment by PEs into HLS sector dropped to $203 million in 2008-09 from $836 million in 2007-08, while the number of deals dropped 51 per cent to 21 from 43 deals. Similarly, VC investments also declined to $48 million from $80 million. In terms of deals, they dropped to 11 from 14.
Council of Scientific and Industrial Research offeres grants for young researchers in a variety of science and math fields. Funds up to three years of research.
Infosys Technologies is looking for acquistion of companies within $50 and $100-million revenue range in the segment of banking and financial services, besides health and life sciences, Infosys COO Kris Gopalakrishnan said.
Global companies, e-commerce platforms and software product firms all want skilled digital workers.
Indian drug makers may lose out on outsourcing contracts as overseas pharmaceutical companies defer their visits to the country in the wake of Mumbai terror attacks, according to industry experts.
The study finds that copper-coated surfaces can significantly reduce the concentration of the influenza-A virus on them, raising hopes that it may also be effective against other strains of the virus.
Manipal Institute of Regenerative Medicine (MIRM) of Manipal University has launched a short term course on Application of Flow Cytometry and Molecular Biology Techniques in Stem Cell Biology and Regenerative Medicine.
'We are going to be overwhelmed by the need for hospital beds. There are simply not enough beds in government hospitals.' 'We will need a large number of medical professionals and without the private sector's involvement, the government won't be able to expand capacity.'
University of Madras offers many programmes from the Department of Zoology. "How to Apply" details found inside.
Central Institute of Medicinal and Aromatic Plants (CIMAP) opens admissions to its PhD programme.
Job portals like Monster.com and Naukri.com affirmed the observation.
National Institute of Virology, Pune, needs research assistants for an upcoming project. Walk-in interview on 12 July 2007.
The arrival of summer in India may have raised hopes that hot and humid weather could slow the COVID-19 progression but virologist Naga Suresh Veerapu believes that outbreak and pandemic occurrences often do not follow seasonality.
While company executives refused to divulge further details, industry sources said that Reliance has earmarked a huge area in the SEZ for the project.
India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.
University of Mysore offers three degree programmes, including a Master's degree in Information Technology.
The Padma Shri winner and eminent scientist speaks to Senior Editor Ajit Jain
US giants are rushing to partner with Indian and Chinese companiestapping their brainpower and saving millions of dollars in the search for breakthrough treatments
India has signed an agreement with the Canadian Light Source and the University of Saskatchewan to promote synchrotron research, a high tech area of nuclear research.
Pavin Rao, a 28-year company veteran, to be second-in-command at Infosys.
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
RPG Life Sciences said on Wednesday it will undergo a restructuring process, wherein its pharmaceutical business and investments will be transfered to two of its group companies.
Canada has offered its partnership in areas like agriculture, mining, life sciences, ICT, financial services and infrastructure. Canada's aim in India was to create new Canadian connections in sectors like agriculture, mining, life sciences, information and communication technology (ICT), financial services and infrastructure, areas where that country's firms have proven expertise. Canadian rep hoped to see Canadian companies becoming active in the Indian market & vice versa.
Assam University, Silchar, invites applications for its various academic programmes for the 2006-07 session.
Ranbaxy board has approved the hive off of its R&D unit, with an 1:4 share swap ratio.
Patni Computer Systems Inc, a wholly-owned subsidiary of Patni Computer Systems, on Monday announced the acquisition of Bridgewater, NJ-based Taratec Development Corp for an aggregate price of $27.2 million in cash.
VIGSR, in Mumbai, offers the first postgraduate diploma in medical genetics in India.
India is one of the fastest growing FDI sources for the United States with investors from the country more interested in US' aerospace and textile sectors.
RPG Life already has marketing tie-ups with Israel's drug major Teva for the EU market and with the US-based Apotex for the Canadian market.
The west is faced with a daunting task on patent expiry, increasing challenges from generics, pipeline showing limited blockbusters, and in addition to that increasing pricing pressure.
BARC invites applications for its PhD programme commencing in September 2008 under the aegis of HBNI.
Biovel Life Sciences (P) Ltd, a biotechnology firm, has inked a licensing agreement with US-based Dowpharma to produce Human Growth Hormone using Pfenex Expression Technology, for the first time globally.
While 2017 was a record year for private equity investments in India after $23.5 billion in 660 deals, 2018 too has begun with a bang.
Institute of Bioinformatics and Applied Biotechnology, Bangalore, invites applications for its Post-graduate Diploma in Bioinformatics and Laboratory Course in Biotechniques programmes.
Despite news of the private equity in the domestic healthcare and pharma industry touching almost Rs 40 crore (Rs 40 million) in the first nine months of the year, PE firms are not exactly bullish about investing in the pharma industry alone. In fact, a closer look at the investments reveals that a larger part of the money is being flown into healthcare delivery systems like hospital chains and not in pharma companies.
Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
Competing with established biotech companies in India such as Wockhardt, Biocon and Reliance Life Sciences, small biotech companies such as Zenotech, BV Biocorp and Intas Biopharma are likely to emerge as major players in biogeneric drugs.
The Bharathidasan University and Mediscan Institute of Medical Education, Chennai invite applications for admission to their job-oriented full-time, two year, diploma programmes.
'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'
